GenoTrim to play a role on the nation's obesity crisis by addressing
genetics associated with hunger and excess weight.
SAN DIEGO, Sept. 11 /PRNewswire/ -- Salugen, Inc., a personalized health and wellness company, announced the launch of GenoTrim, a DNA-based nutritional solution for weight management*. Attempts to achieve a healthy weight through both standard weight reduction strategies and numerous "gimmicks" have proven unsuccessful for the 58 million overweight individuals in the U.S. GenoTrim uniquely identifies specific genetic factors affecting hunger, metabolism and body composition that may contribute to the weight challenges of many of these individuals.
"GenoTrim tests for five key genes associated with the hereditary contributors to weight and hunger. From the genetic analysis, the individual is provided a nutrient formulation guided by their genetic profile," stated Lonna J. Williams, COO and SVP of Marketing at Salugen, Inc. Williams goes on to say, "GenoTrim is not a lose-weight-quick or magic pill. By addressing gene mutations inhibiting one's ability to manage weight, it provides a measure of control and help to break through obstacles encountered in previous weight loss efforts. Importantly, healthy eating and exercise are essential to proper weight management."
GenoTrim and its ingredients are supported by numerous published
clinical studies including the award winning study Dietary Investigation to
Evaluate Treatments (D.I.E.T.), lead by Dr. Ken Blum, Chief Scientific
Officer of Salugen and a professor in the Department of Physiology and
Pharmacology at Wake Forest University School of Medicine. Compared to most
nutritional supplements, GenoTrim ingredient combinations have been proven
in published, randomized, double-blinded placebo-controlled studies to
result in weight loss. In three published clinical studies, GenoTrim
resulted in an average weight loss of 12.8 lbs, 17.15 lbs and 26.96 lbs in
Copyright©2007 PR Newswire.
All rights reserved